South Korea IVF (in-vitro fertilization) Market Research Report, 2029

Infertility, a difficult trial influencing couples around the world, is a multi-layered issue that has collected critical consideration in South Korea. The nation, known for its high level medical services framework and mechanical ability, has seen an ascent popular for Infertility therapies as of late. As couples face challenges considering, they go to various choices inside the sweeping scene of Infertility medicines accessible in the country. In South Korea, Infertility treatment choices range from essential prescriptions to cutting edge helped regenerative advances (Craftsmanship) like in vitro preparation (IVF). The accessibility and availability of these medicines have expanded significantly, with various facilities and clinics offering specific administrations the country over. One of the essential purposes for the thriving interest for Infertility medicines in South Korea is the moving cultural standards and the deferment of being a parent. As additional couples focus on their professions and monetary strength, they postpone beginning a family, prompting an expanded commonness of Infertility issues. Subsequently, the market for Infertility medicines has seen consistent development, driven by the need to address these difficulties. Headways in clinical innovation and methods have added to the adequacy and achievement paces of Infertility medicines in South Korea. Centers outfitted with cutting edge offices and gifted clinical experts give exhaustive consideration to couples looking for help with their excursion towards life as a parent. Notwithstanding the headways and expanded availability, Infertility medicines in South Korea actually represent specific difficulties. Cost stays a huge element, for certain medicines being monetarily restrictive for some couples. Because of these difficulties, endeavors are in progress to make Infertility medicines more reasonable and open to a more extensive populace. Government drives, combined with headways in medical care supporting components, mean to lighten the monetary weight related with these therapies. According to the research report "South Korea Infertility Treatment Market Research Report, 2029," published by Actual Market Research, the South Korea infertility treatment market is anticipated to grow at more than 9.91% CAGR from 2024 to 2029. The infertility treatment market in South Korea is ready for huge development, driven by a few key elements. There's an increasing interest because of expanding fruitlessness rates, energized by variables, for example, postponed childbearing, way of life changes, and ecological elements. As couples face challenges considering normally, they go to helped conceptive advancements (Workmanship) like in vitro treatment (IVF) and intracytoplasmic sperm infusion (ICSI) for arrangements. South Korea's high level clinical innovation and framework further reinforce this interest, drawing in homegrown patients as well as clinical vacationers from adjoining nations looking for excellent and reasonable medicines. Government support assumes a urgent part in driving business sector development. The South Korean government offers sponsorships and impetuses for couples going through Infertility medicines, making these systems more open and reasonable. Continuous endeavors to bring issues to light about Infertility and accessible treatment choices add to a growing patient base. Changing cultural standards and mentalities toward family-fabricating additionally add to showcase development. South Korea is seeing developing viewpoints on elective family-building strategies, for example, single being a parent, same-sex couples, and elective egg freezing. As cultural marks of shame encompassing fruitlessness reduce, more people and couples are looking for treatment choices to satisfy their craving for being a parent. Looking forward, the Infertility treatment market in South Korea is supposed to grow. Factors like the maturing populace, headways in clinical innovation, and expanding acknowledgment of fruitlessness medicines are probably going to fuel this development. The market is expected to profit from continuous exploration and advancement in regenerative medication, prompting further developed achievement rates and more customized treatment draws near.

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

In a fresh non-donor IVF cycle, the woman undergoes ovarian stimulation to produce multiple eggs, which are then retrieved and fertilized with sperm in the laboratory. The resulting embryos are typically transferred into the woman's uterus within the same cycle. South Korea boasts advanced medical technology and a skilled workforce, making fresh non-donor IVF cycles widely available and successful. The country's high-quality healthcare infrastructure contributes to the effectiveness of these cycles, resulting in favorable outcomes for many patients. Compared to some other countries, South Korea may have shorter waiting times for IVF treatment and higher success rates due to its efficient healthcare system and emphasis on technological innovation. In a frozen non-donor IVF cycle, embryos created from a previous fresh cycle are frozen and stored for future use. They embryos are thawed and transferred into the woman's uterus in a subsequent cycle. South Korea has seen a growing trend towards frozen embryo transfers due to their advantages, including higher success rates, lower risk of ovarian hyperstimulation syndrome (OHSS), and better synchronization of embryo implantation with the uterine lining. This trend aligns with global practices, as frozen embryo transfers become increasingly popular worldwide. In a frozen donor IVF cycle, frozen embryos from a donor egg and sperm are transferred into the recipient's uterus after thawing. This cycle is commonly used for couples facing female infertility issues or same-sex couples. South Korea's infertility treatment market offers options for frozen donor IVF cycles, although regulations regarding donor gametes may vary compared to other countries. In a fresh donor IVF cycle, eggs from a donor are retrieved and fertilized with sperm in the laboratory. The resulting embryos are then transferred into the recipient's uterus within the same cycle. South Korea's regulations and cultural attitudes towards donor gametes may influence the prevalence of fresh donor IVF cycles compared to other countries. Conventional IVF, a cornerstone of assisted reproductive technology (ART), offers hope to couples facing infertility challenges worldwide. In this method, a woman's ovaries are stimulated with fertility medications to produce multiple eggs, which are then retrieved and fertilized with sperm in a laboratory setting. This process allows for the creation of embryos, which are subsequently transferred back into the woman's uterus, aiming to establish a successful pregnancy. Alongside conventional IVF, variations such as IVF with Intracytoplasmic Sperm Injection (ICSI) offer tailored solutions for specific infertility issues. ICSI involves the direct injection of a single sperm into each mature egg, addressing male factor infertility such as low sperm count or poor sperm motility. Additionally, IVF with donor eggs provides a pathway to parenthood for women unable to produce viable eggs of their own, utilizing eggs from healthy donors to create embryos for transfer. These techniques, alongside advancements like preimplantation genetic testing (PGT) and frozen embryo transfer (FET), contribute to the comprehensive landscape of infertility treatment options. In the context of South Korea's infertility treatment market compared to other countries, several factors come into play. South Korea's reputation for cutting-edge medical technology, coupled with a robust regulatory framework, likely positions it as a favorable destination for infertility treatments. Cultural attitudes and awareness around ART may influence demand and accessibility, while cost and insurance coverage also play significant roles in patient decision-making. Success rates and the quality of care provided by fertility clinics are paramount considerations for patients seeking treatment. While South Korea's advanced healthcare infrastructure and expertise may place it competitively, a comprehensive analysis of data, including success rates, patient outcomes, and regulatory environments, would be necessary to make a nuanced comparison with other countries. Ultimately, the effectiveness and accessibility of infertility treatments in South Korea contribute to the broader global conversation on reproductive health and family-building options, offering hope and support to individuals and couples navigating the complexities of infertility. Fertility clinics specialize in providing a range of assisted reproductive technologies (ART) and infertility treatments, including in vitro fertilization (IVF), intrauterine insemination (IUI), and fertility preservation. These clinics are often the primary point of care for individuals and couples seeking infertility treatment. In South Korea, fertility clinics play a crucial role in the infertility treatment market, offering advanced ART procedures and personalized care to patients. These clinics are equipped with state-of-the-art facilities and staffed by highly trained reproductive specialists. Compared to some other countries, South Korea's fertility clinics may emphasize technological innovation and research, contributing to high success rates and patient satisfaction. Hospitals and surgical centers in South Korea provide a wide range of medical services, including infertility treatments. In South Korea, hospitals and surgical centers benefit from advanced medical technology and skilled healthcare professionals, making them well-equipped to handle complex infertility cases. Compared to some other countries where fertility clinics operate independently, South Korea's hospital-based fertility services offer advantages such as access to broader healthcare resources, multidisciplinary care teams, and advanced surgical capabilities. Cryobanks play a crucial role in the infertility treatment market by storing and preserving gametes and embryos for future use. In South Korea, cryobanks adhere to stringent regulations and quality standards to ensure the safety and viability of stored gametes and embryos. Compared to some other countries, South Korea's cryobanks benefit from advanced cryopreservation techniques and a robust regulatory framework, instilling confidence in patients regarding the quality and reliability of stored reproductive materials. Research institutes play a vital role in advancing the field of reproductive medicine through scientific research, clinical trials, and technological innovation. These institutions contribute to the development of new infertility treatments, diagnostic techniques, and reproductive technologies. In South Korea, research institutes focused on reproductive medicine collaborate with academic institutions, hospitals, and fertility clinics to drive innovation and excellence in patient care. Compared to some other countries, South Korea's research institutes in reproductive medicine may benefit from strong government support, investment in scientific infrastructure, and a culture of innovation. These factors contribute to the country's leadership in scientific research and technological advancement in the field of infertility treatment.

Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Ask an Expert

Kripa Shah

Senior Analyst

Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • IVF market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By cycle • Fresh Non-donor IVF Cycle • Frozen Non-donor IVF Cycle • Frozen donor IVF Cycle • Fresh donor IVF Cycle

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By Conventional IVF • Conventional IVF • IVF with ICSI (Instracytoplasmic Sperm Injection) • IVF With Donor Eggs • other By End user • Fertility Clinics • Hospital & Surgical Centers • Cryobanks • Research institute The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the IVF industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.